Recent clinical studies carried out in sub-Saharan Africa have confirmed scientists’ worst fears: malaria parasites have developed resistance to a key family of drugs used to protect against them. Researchers have long suspected this, as signs associated with drug resistance such as gene mutations had already been detected in previous studies. However, the confirmation of resistance arising in Africa raises major concerns, as the continent alone carries over 90% of the global malaria burden.